Hot Sale Peptide Ghk-Cu CAS 49557-75-7 10mg Nad+ Semax Retatrutide Epithalon
150 Inquiries
49557-75-7
Pharmaceutical Grade
99%
Chinese mainland
any
1000mg*10vials
2026-09-18
Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)
-
Product Description
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceCopper peptide GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine. The tripeptide has strong affinity for copper(II) and was first isolated from human plasma. It can be found also in saliva and urine.
ChEBI: Gly-His-Lys is a tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence. It has a role as a metabolite, a chelator, a vulnerary and a hepatoprotective agent.Basic Info-
Product Name:
Copper Peptide
Other Name:GHK Cu Copper Peptide;L-Lysine,glycyl-L-histidyl-;Copper Peptide powder (GHK-cu);GHK Cu Copper Peptide GHK.Cu GHK-Cu;Liver Cell Growth Factor(GHK);GHKcu/Growth-Modulating peptide;(Gly-His-Lys)2Cu.xHAc;AHK-Cu (Copper Peptide)
CAS No.:49557-75-7
Molecular Formula:C14H24N6O4
InChIKeys:MVORZMQFXBLMHM-QWRGUYRKSA-N
Molecular Weight:340.38
EC Number:1592732-453-0
Color/Form:Off-White
Categories:
Characteristics-
Density:
1.324
Melting Point:>144°C (dec.)
Boiling Point:831.0±65.0 °C(Predicted)
PKA:3.11±0.10(Predicted)
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2–8 °C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semag lutide,Tirzepatide,Retatrutide,raw material,GHK-CU,TB500(Thymosin B4 AceTate)
-
Location:
Room 1002-C3973, No. 80, Yongtai Modaonan Street, Yongping Subdistrict, Baiyun District, Guangzhou City
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
45
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History150 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Cosmetic Copper GhkCU Peptide CAS 49557-75-7 Peptide 50mg Ghk-Cu
2 MT Nov 6, 2023 
Malaysia
High quality 98% up Copper Peptide GHK-Cu powder CAS 49557-75-7
1 KG Oct 19, 2023
United States
Copper Peptide 99% Copper Peptide Ghk-Cu Powder Ghk Cu CAS 49557-75-7
1 KG Mar 26, 2026 
China
Glycyl-l-histidyl-l-lysine
10 KG Oct 24, 2023 
Sweden
GHK-Cu
1 KG Mar 17, 2026 
Malta
Copper peptide GHK-CU
1000 MT Aug 8, 2026
United States
Ghk-cu
20 MT Jul 17, 2026 
Brazil
Ghk-cu
30 MG Jul 14, 2026 
Peru
GHK-Cu
15 MG Jul 13, 2026
Malaysia
GHK-Cu
1 G Jul 9, 2026
Brazil
GHK-Cu
50 MG Jul 9, 2026 
United Kingdom
GHK-cu
50 MG Jul 3, 2026
United States
Cooper peptide
1 G Jun 30, 2026 
United Arab Emirates
Ghk-cu
10 MT Jun 15, 2026
United Kingdom
GHK-CU
5 KG Jun 11, 2026
United States
GHK-CU
10 MT Jun 5, 2026
United States
Cosmetic Copper GhkCU Peptide 50mg Ghk-Cu
1 PCS Jun 3, 2026
Malaysia
GHK-Cu
1 PCS May 27, 2026 
France
GHk-cu
200 MG May 25, 2026 
Australia
GHK. - CU
4000 MG May 20, 2026 Post an enquiry for this product
